The industry studies that showed a decongestant was effective turned out to be flawed. Sound familiar?
Journal Editorial Report: The week's best and worst from Kyle Peterson, Mary O’Grady and Dan Henninger. Images: AP/Reuters Composite: Mark Kelly
If DayQuil never seemed to unstuff your nose, now you know why: Its core decongesting ingredient, phenylephrine, doesn’t work.Continue reading your article with
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
COVID vaccine just approved should be skipped by Florida residents under age 65, says Gov. DeSantisFlorida Gov. Ron Desantis, during a virtual roundtable on Wednesday, told residents that if they are under the age of 65, they should not get the updated COVID-19 vaccine.
続きを読む »
Bashing boosters, DeSantis contrasts with Trump and worries health expertsDeSantis’s posture against the covid shots is at odds with the advice of leading public health officials and experts and shows how he is seeking to make his position a 2024 campaign issue.
続きを読む »
U.S. COVID levels hovering near 2020 initial peak, WHO urges those at high risk to take boostersThe latest data from the CDC shows that U.S. COVID-19 hospitalizations and deaths are still increasing, approaching the Delta peak of late 2021. This indicates that although the official pandemic state may have ended, COVID-19 is still a significant concern.
続きを読む »
Flu vaccine booking in Jersey beginsIt will be rolled out in schools from Monday and to all eligible islanders from Tuesday.
続きを読む »
BioNTech and CEPI to partner to advance an mRNA-based Mpox vaccineBioNTech SE and the Norwegian-based Coalition for Epidemic Preparedness Innovations, or CEPI, said Monday they are partnering to advance an mRNA-based Mpox...
続きを読む »
NY nurse guilty in $1.5M COVID vax scam blames 'government mandates'Julie DeVuono — who raked in $1.5 million selling fake vaccine cards during the COVID-19 pandemic — pleaded guilty on Friday to forgery and money laundering.
続きを読む »